IMEGEN

(Biotechnology, Medicine and Health)

Introduction

IMEGEN is a laboratory of genetic studies founded in 2009 and formed by around 50 professionals with more than 20 years of experience in genetics and genomics.  The company performs all kinds of analysis, using the most innovative techniques on the market, with a large group of geneticists who advise the patient in the different processes to offer the best genetic diagnosis to the patient and covering all stages of life:  prenatal, childhood and adulthood.

Imegen also has a sub-brand, Imegen Agro, focused on the agri-food sector, with more than 15 years of experience, designing tests based on DNA analysis, in order to guarantee the quality of food products.

Since its creation, the company has opted for technological development and innovation, to put at the service of the patient the best genetic studies that contribute to a guarantee of better quality of life.  It also actively promotes the process of technology transfer, promoting the exploitation of knowledge generated in the academic sphere, as well as the transmission of research results to the clinical laboratory, co-operation with public and private institutions, and it participates in research projects at national and international levels.

Download Impulse to Business Development Programme (PIDE)'s file

Technology offer

Technical Specifications
  • Development and commercialisation of genetic diagnostic services of clinical importance.
  • Use of the most innovative molecular technologies for the development of molecular analysis (DNA sequencing, real time PCR, MLPA, gene capture, CGH arrays, etc).
  • Dynamic portfolio in constant growth, thanks to the implementation in minimum time of diagnostic protocols of any human genetic disease described in the scientific literature.
  • Bio-technological solutions and on-demand trials, both for application in the clinical laboratory and for the food industry.
  • Management, development and execution of research projects as a complement to the research capabilities of the company, industry, hospitals, universities and research centers.
  • Technical consultancy and quality services.
Benefits of Technology

INNOVATIVE ASPECTS

  • Comprehensive system for managing samples and information through the web itself.
  • Development of customised solutions adapted to the client ´s needs.
  • Continuous improvement of processes, adapted to quality standards.
  • Adaptation of protocols to new technologies.
  • Constant investment in R+D + I for the development of new services and products.
  • Internationalisation of services.

COMPETITIVE ADVANTAGES

  • Integral genetics service applied to medicine:  more than 15 years of experience in genetics and genomics.  Geneticists accredited by the AEGH.
  • Permanent communication with the medical and scientific community.
  • Participation in the main national and international genetics forums.
  • Continuous development of new genetic analysis.
  • Development of especially complex genetic analysis.
  • Minimum response times with adjusted costs.
  • Update and constant optimisation of compapny´s own technologies.
  • Current quality criteria.
Technology Applications
  • Genetic diagnosis of genetic diseases:  more than 400 pathologies in the areas of oncology, pediatrics, neurology, cardiology and hematology, amongst others.
  • Prenatal genetic diagnosis.
  • Pharmacogenetics
  • Hereditary cancer.
  • Agri-food quality.
Sectors to which company is directed
  • Human health and quality nutricion
  • Public health, private health, R & D centres, Universities, Health Ministries, food industry, quality consultancies and analysis laboratories.

Team

Ángela Pérez Pérez - Chief Executive Officer

Bachelor Degree in Biological Sciences and an MBA.

Dr. Manuel Pérez Alonso - Scientific Advisor

PhD in Molecular Genetics

Dr. Javier García Planells - Chief Scientific Officer

PhD in Biological Sciences

Dr. Carlos Ruiz Lafora – Chief Technical Officer

PhD in Biological Sciences

Dra. María García Hoyos – Head of Medical Genetics

PhD in Biological Sciences.

Raquel Carrero Planes - Head of Quality Control and RRHH

Degree in Biological Sciences and Specialist in Management and Quality Control from The Polytechnic University of Valencia

IMEGEN company news

IMEGEN creates an online platform to personally meet the demands of its hereditary cancer testRead more »
Ángela Pérez, CEO of Imegen, receives the award for Women Entrepreneurs granted by the City of PaternaRead more »
Specialists from the Science Park tackle how to deal with longevity and precision medicine at the Longevity World ForumRead more »

Contact information

Ángela PérezManagerinfo@imegen.es Phone: (+34) 963 212 340
https://www.imegen.es